Target Healthcare REIT

Result of General Meeting
RNS Number : 7651Q
Target Healthcare REIT PLC
01 March 2021
 

1 March 2021

TARGET HEALTHCARE REIT PLC (the "Company")

RESULTS OF GENERAL MEETING

At a general meeting of the Company's shareholders held at 12 noon today, the resolutions approving the recommended proposals in respect of the issue of new Ordinary Shares (the "New Shares") on a non pre-emptive basis pursuant to an initial placing, offer for subscription, intermediaries offer (together, the "Initial Issue") and placing programme of New Shares were voted on by way of a poll and duly passed by shareholders.

In addition, the Board is pleased to confirm that the Board has today allotted 54,054,054 New Shares in aggregate to subscribers under the Initial Issue (subject only to Admission on 3 March 2021).

The full text of all the resolutions can be found in the notice of meeting (contained in the Circular published by the Company on 12 February 2021), copies of which are available for viewing at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. It is also available for download from the Company's website: www.targethealthcarereit.co.uk.

The results of the poll incorporating the proxy votes lodged before the general meeting, which should be read alongside the notice of meeting, are noted below and will be available shortly at www.targethealthcarereit.co.uk.

 

For

Against

Withheld

 

Number of votes

%

Number of votes

%

Number of votes

1) Ordinary Resolution

285,808,612

98.3

5,058,226

1.7

412,406

2) Special Resolution

275,432,654

98.3

4,898,977

1.7

10,947,612

 

Enquiries:

 

Target Fund Managers Limited (Investment Manager to the Company)                                            

Kenneth MacKenzie

 

+44 1786 845 912

Gordon Bland

 

+44 1786 845 912

 

 

 

Stifel Nicolaus Europe Limited

 

 

Mark Young

mark.young@stifel.com

+44 20 7710 7600

Mark Bloomfield

mark.bloomfield@stifel.com

+44 20 7710 7600

Rajpal Padam

rajpal.padam@stifel.com

+44 20 7710 7600

 

 

 

FTI Consulting

 

 

Dido Laurimore

TargetHealthcare@fticonsulting.com

+44 20 3727 1000

Claire Turvey

 

 

Richard Gotla

 

 

       

 

Capitalised terms used and not otherwise defined in this announcement have the meaning given to them in the Prospectus.

Important Information

The information contained in this announcement is given at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment from time to time.

This announcement does not contain or constitute an offer for sale or the solicitation of an offer to purchase securities in the United States. The New Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from or in a transaction not subject to the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of the New Shares in the United States.

This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, any securities in any jurisdiction. No offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, any securities will be made in any jurisdiction in which such an offer or solicitation is unlawful. The information contained in this announcement is not for release, publication or distribution to persons in the United States, Canada, Australia, the Republic of South Africa , New Zealand or Japan, and should not be distributed, forwarded to or transmitted in or into any jurisdiction, where to do so might constitute a violation of local securities laws or regulations.

Dickson Minto W.S, which is authorised and regulated by the Financial Conduct Authority, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Dickson Minto W.S. or advice to any other person in relation to the matters contained herein.

Stifel Nicolaus Europe Limited, which is authorised and regulated by the Financial Conduct Authority, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Stifel Nicolaus Europe Limited or advice to any other person in relation to the matters contained herein.

None of the Company, Target Fund Managers Limited, Dickson Minto W.S. or Stifel Nicolaus Europe Limited, or any of their respective affiliates, accepts any responsibility or liability whatsoever for or makes any representation or warranty, express or implied, as to this announcement, including the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of the announcement or its contents or otherwise arising in connection therewith. The Company, Target Fund Managers Limited, Dickson Minto W.S. and Stifel Nicolaus Europe Limited, and their respective affiliates, accordingly disclaim all and any liability whether arising in tort, contract or otherwise which they might otherwise have in respect of this announcement or its contents or otherwise arising in connection therewith.

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM, THE REPUBLIC OF IRELAND OR THE NETHERLANDS (AND, IN THE CASE OF THE NETHERLANDS, ONLY TO PROFESSIONAL INVESTORS)), CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMSSFFMFEFSEID